Evidence map›Paper›PMID 31249458›Full record

ReviewActa Cardiologica Sinica2019

3D Bioprinting Methods and Techniques: Applications on Artificial Blood Vessel Fabrication.

Theodore G Papaioannou, Danae Manolesou, Evangelos Dimakakos, Gregory Tsoucalas, Manolis Vavuranakis, Dimitrios Tousoulis

Abstract readReview
In one paragraph

Review in Acta Cardiologica Sinica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. The FDA's plan to phase out animal testing.Trends in biotechnology · 2026
    Article
  2. Review
  3. Review
  4. Tracheal Tissue Engineering: Advances and Challenges.Bioengineering (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Review
  7. Dynamic Hydrogels in Breast Tumor Models.Gels (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Review
  10. Review on Advancement of AI in Cell Engineering and Molecular Biology.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  11. Article
  12. Article
  13. Technique for rapidly forming networks of microvessel-like structures.bioRxiv : the preprint server for biology · 2024
    Article
  14. GelMA synthesis and sources comparison for 3D multimaterial bioprinting.Frontiers in bioengineering and biotechnology · 2024
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Theodore G PapaioannouBiomedical Engineering Unit, First Department of Cardiology, Medical School.
Danae ManolesouBiomedical Engineering Unit, First Department of Cardiology, Medical School.
Evangelos DimakakosBiomedical Engineering Unit, First Department of Cardiology, Medical School.
Gregory TsoucalasFaculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Manolis VavuranakisThird Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Athens.
Dimitrios TousoulisBiomedical Engineering Unit, First Department of Cardiology, Medical School.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D) printing has rapidly evolved, with major applications in the field of medicine. One of the greatest advances leading to 3D bioprinting was the development of biomaterials, cells and supporting components for the fabrication of functional living tissues. Several different methods and techniques of 3D bioprinting are briefly described in this review article, and applications of 3D printing for the fabrication of artificial blood vessels and grafts are presented. Advances in additive manufacturing techniques, medical imaging modalities, biomaterials and cellular engineering will lead to further developments in the fabrication of patient-specific vascular tissue constructs. Future multidisciplinary research and innovations are expected to further transform the fields of tissue engineering and regenerative medicine.

Indexed as

Additive manufacturingArteryTissue engineeringVascular graft

Identifiers

PMID31249458
PMCPMC6533576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.